If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals. The drug, Journavx, or suzetrigine, was approved to treat moderate to severe ...
Mexico agreed to reinforce its border with 10,000 members of the National Guard to stem fentanyl trafficking and illegal ...
Merck (MRK) announced the U.S. FDA has accepted for priority review a supplemental new drug application seeking approval of Welireg, Merck’s oral hypoxia-inducible factor-2 alpha inhibitor ...
This marks Supernus Pharma's fourth attempt to gain FDA approval for SPN-830. In November 2020, the U.S. regulatory agency refused to accept for review the New Drug Application for SPN-830 ...
President Donald Trump's threatened tariffs against Canada and Mexico risked blowing up North America's economy.
Indonesian authorities are set to return an ailing French national who has been on death row in the Southeast Asian country, under an arrangement between the two nations.
When it comes to health tracking, the Galaxy Watch 7 offers sleep monitoring, measures body composition (like BMI and fat percentage), takes an ECG, and even features FDA-approved sleep apnea ...
Democratic senators are expressing alarm about planned budget reallocations at the Food and Drug Administration that they fear will threaten the nation’s food safety system. In a letter to FDA ...
US tariffs on Canada will be paused for 30 days, Prime Minister Justin Trudeau said Monday after a call with President Donald Trump in which Trudeau pledged stronger border measures to stop crossings ...
To help combat the nation’s chronic disease crisis, the FDA has announced a proposal for a rule that would require front-of-package labeling for nutritional information. If finalized ...
Zyn is a subsidiary of Philip Morris International. “To receive marketing authorizations, the FDA must have sufficient evidence that the new products offer greater benefits to population health ...